Septerna, Inc. (SEPN) Net Margin
- 2026-06-30: Net Margin -48.73%.
- 2026-03-31: Net Margin -32.56%.
- 2025-12-31: Net Margin -44.52%.
- 2025-09-30: Net Margin 38.02%.
Complete source-backed net margin history.
- Available history
- 2023-09-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -48.73% |
| 2026-03-31 | -32.56% |
| 2025-12-31 | -44.52% |
| 2025-09-30 | 38.02% |
| 2025-06-30 | -20872.27% |
| 2025-03-31 | -9806.39% |
| 2024-12-31 | -9749.06% |
| 2024-09-30 | -11660.80% |
| 2024-06-30 | -4462.16% |
| 2024-03-31 | -4447.00% |
| 2023-12-31 | 29571.19% |
| 2023-09-30 | -33166.67% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -106.37% |
| 2024-12-31 | -6678.88% |
| 2023-12-31 | 2768.21% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |